Desvenlafaxine Completed Phase 3 Trials for Depression Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01527786Functional Outcome in Postpartum Depression in Women Treated With Desvenlafaxine
NCT00329147Study Evaluating the Effects of DVS SR and Paroxetine on the Pharmacokinetics of Desipramine in Healthy Subjects